You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

Details for Patent: 8,592,434

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,592,434 protect, and when does it expire?

Patent 8,592,434 protects SITAVIG and is included in one NDA.

This patent has fourteen patent family members in thirteen countries.

Summary for Patent: 8,592,434

Title:	Mucoadhesive buccal tablets for the treatment of orofacial herpes
Abstract:	The present invention relates to the treatment or prevention of mucocutaneous herpes simplex virus diseases using prolonged release mucoadhesive buccal tablets comprising an acyclic guanosine antiviral agent. These tablets are particularly suitable for the treatment or prevention of orofacial herpes.
Inventor(s):	Attali; Pierre (Vincennes, FR), Costantini; Dominique (Paris, FR), Lemarchand; Caroline (Paris, FR)
Assignee:	BioAlliance Pharma SA (Paris, FR)
Application Number:	12/634,225
Patent Claim Types: see list of patent claims	Use; Dosage form;

Drugs Protected by US Patent 8,592,434

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Lnhc	SITAVIG	acyclovir	TABLET;BUCCAL	203791-001	Apr 12, 2013		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y			TREATMENT OF HERPES LABIALIS	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 8,592,434

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	2782779	⤷ Try a Trial
China	102652016	⤷ Try a Trial
Denmark	2509586	⤷ Try a Trial
European Patent Office	2335690	⤷ Try a Trial
European Patent Office	2509586	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.